Brendan Teehan, EVP, COO, HEAD OF COMMERCIAL at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,280 shares at $17.90 ($184K) on 2024-03-27, disclosed to the SEC on 2024-03-27.
Open-market sale of $184k ACAD by EVP, COO, HEAD OF COMMERCIAL. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.90 | 5,140 | $92K | 50.0% |
| 2 | $17.90 | 5,140 | $92K | 50.0% |
| Total | $17.90 avg | 10,280 | $184K | 100% |
| Filing → |
| ACAD | SELL | 2024-05-03 | $118K | — | Filing → |
| ACAD | SELL | 2024-04-09 | $46K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $15K | — | Filing → |